Semiconductor cyclicality — the recovery is priced in; a demand stall or China/auto air-pocket de-rates a 30× stock fast
One-line thesis. ADI is a genuinely elite analog/mixed-signal franchise — 64% gross margins, $4.3B free cash flow, and a diversified industrial/auto book — now emerging from a deep chip-cycle trough (FY25 revenue +17%), but the stock at ~56× GAAP / ~31× forward earnings already discounts a clean recovery, so the honest call is Watch until either the multiple cools or the cyclical upturn proves durable.
◆ Synthos call — HoldADI is a solid business largely reflected at ~$400 — fine to keep, no reason to chase; it gets interesting again below ~$340.
Downside Risk (lower = safer)
6/10 · High
Investment-grade (net-debt/EBITDA 1.0×) & moderate beta 1.18 — but 56× GAAP trailing, cyclical demand, and China/auto exposure.
Growth Quality
6/10 · High
Recovering off a cyclical trough; ~14% fwd revenue CAGR, 64% gross margin, high ROIC on tangible base, durable analog moat — but returns diluted by acquisition goodwill.
Exponential Potential
4/10 · Moderate
Cyclical rebound, not secular acceleration; a $184B mature analog leader with limited room to multibag.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 28%/yrTo justify today’s $377, earnings would have to compound roughly 28% a year for 10 years (9% discount rate). Analysts forecast ~9%/yr, so the market is pricing in MORE than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
Analog Devices makes the tiny, unglamorous chips that let machines sense and manage the real world — chips that turn temperature, sound, motion, and voltage into digital signals, and manage power inside factories, cars, and phones. It is one of the two or three best companies on earth at this, and it keeps about 64 cents of gross profit on every sales dollar — very high for a chipmaker.
The catch: this is a cyclical business. When factories and carmakers over-order, ADI booms; when they work down inventory, sales drop. ADI just came out of a down-cycle and sales are climbing again (up 17% last year). But the stock is expensive — you're paying about 31 times next year's expected profit — which already assumes the good times keep rolling.
Our verdict is Watch: a wonderful business at a full price, with almost no independent expert coverage behind it in our system. Not a screaming buy, not a sell.
Here's what our three scores mean in everyday terms:
Downside Risk 6/10 (a bit above average). The balance sheet is solid and the dividend is safe, but the high price and the boom-bust nature of chips mean a disappointment could hurt.
Growth Quality 6/10 (good, not great). Very profitable with a durable moat, but growth is a rebound off a low base rather than something new and unstoppable.
Exponential Potential 4/10 (low-moderate). It's a big, mature company. Expect steady compounding over a full cycle, not a fast double.
The one big worry: the chip cycle. The stock is priced as if the recovery is a sure thing. If industrial or automotive demand stalls — or China weakens — a highly-valued stock like this can fall hard.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLK (sector)), set to 100 a year ago
Solid = ADI · dashed = S&P 500 · dotted = XLK (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$377.16
Market cap$184B
P/E trailing16×
P/E FY26E / FY27E31× / 25×
EV / Sales14.9×
EV / EBITDA30.5×
Gross margin64.5%
Net margin26.0%
Dividend yield1.11%
Beta1.183
52-wk range$221 – $445
RSI(14)40
50 / 200-DMA$409 / $318
12-mo return+57% (SPY +21%)
Street target$454 ($360–$550)
Analyst grades43 Buy · 11 Hold · 0 Sell
FMP ratingB-
Next earnings2026-08-05
What the experts actually said 1 traceable claims on ADI · showing the highest-conviction voices
“Power and thermal are bottlenecks; integrated voltage regulation (40V→1V) loses much power—power management is a very good area (ADI bought Empower).”
No Priorsbullishconviction 722026-06-18no_priors-asCgCv2XB4s:0b66ecb601
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
Analog Devices (Nasdaq: ADI), founded 1965 and headquartered in Wilmington, Massachusetts, is a global leader in analog, mixed-signal, and power-management integrated circuits — data converters, amplifiers, RF/microwave ICs, MEMS sensors, and power/battery-management chips. These are the components that bridge the physical and digital worlds: converting real-world signals (temperature, pressure, motion, radio) into data and back, and managing power delivery. ADI's franchise is built on ~24,000 employees, tens of thousands of catalog parts, long product lifecycles (often 10+ years), and deep customer design-in stickiness. Fiscal year ends late October / early November.
Revenue mix — end market (FY2025, $11.02B, from filings):
The industrial concentration is a quality signal (diversified across tens of thousands of customers, no single part dominates) but also the source of the recent downturn — industrial fell from $6.56B (FY23) to $4.31B (FY24) before recovering to $4.93B (FY25), the clearest picture of the chip-inventory cycle ADI just traversed.
Revenue mix — geography (FY2025): Non-US $7.78B vs United States $3.24B (~29% US). By country: China $2.86B (26%), Europe $2.29B, Rest of Asia $1.49B, Japan $0.99B. China exposure at ~26% is both a growth channel and a geopolitical/tariff risk (§11).
2. The expert thesis — why coverage is thin (traceable)
Honest disclosure first: ADI has almost no expert coverage in the Synthos knowledge base. total_claims = 1. There is exactly one net-bullish voice, and no cautionary voice on file. This verdict is therefore fundamentals- and quant-driven, not a conviction call built on a broad expert panel — the opposite of a name like LLY (13 voices, 251 claims). We say this plainly so the reader does not mistake thin coverage for high conviction.
The single traceable claim:
Power management is a structural bottleneck, and ADI is positioned in it. no_priors (no_priors-asCgCv2XB4s:0b66ecb601, bullish, conviction 72, skill 1.0, 2026-06-18): "Power and thermal are bottlenecks; integrated voltage regulation (40V→1V) loses much power — power management is a very good area (ADI bought Empower)." This is a real, specific, on-thesis point: as AI data centers and edge devices push power density, high-efficiency voltage conversion becomes a premium problem, and ADI's power portfolio (bolstered by the Empower Semiconductor acquisition) is levered to it. It is one supportive data point — not a panel.
Composite note. With n=1, there is no signed net to speak of beyond a single +72-conviction vote. We do not manufacture conviction from it. The Watch verdict rests on the financials, valuation, cycle position, and moat analysis that follow — the KB claim is corroborating color on the power-management leg, nothing more.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
6 · Moderate-High
Investment-grade (net-debt/EBITDA 1.0×, interest coverage 12×, $4.3B FCF, safe 1.1% dividend) and only moderate beta 1.18 — but 56× GAAP trailing / ~31× forward leaves little margin, and semis are cyclical with ~26% China and 30% auto exposure.
Growth Quality
6 · Good
64% gross margin, ~40% operating-cash-flow margin, high return on tangible assets (24%) and a durable analog moat — but headline ROE is only ~10% (diluted by ~$27B Maxim/Linear goodwill), and FY25's +17% is a rebound off a trough, not organic secular growth.
Exponential Potential
4 · Low-Moderate
Forward revenue CAGR ~14% is real but is cyclical recovery, not acceleration; a mature $184B leader in a slow-growing (if durable) category. Room to multibag is limited.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores above summarize them. All EPS figures are the adjusted (non-GAAP) basis the Street estimates use — ADI's GAAP EPS runs materially lower due to ~$2B/yr acquisition amortization.
Case
Key assumptions
Fair value
Bull
Industrial + auto up-cycle runs hot; power/BMS content gains compound; China holds. FY27E adj. EPS beats to ~$16 (vs $14.86 cons); market pays a premium ~31×.
~$500 (+33%)
Base(our anchor)
Recovery proceeds roughly to plan — FY27E adj. EPS ~$14.86; a high-quality but cyclical compounder earns a ~27× through-cycle multiple.
~$400 (+6%)
Bear
Chip cycle rolls over / China-auto air-pocket; FY27E adj. EPS stalls near ~$13; multiple de-rates toward the low end ~23× as cyclicality reasserts.
~$300 (−20%)
Synthos fair value = the base case, ~$400 (+6%), with the full $300–$500 span as the honest range. Our base sits below the Street's $453.57 consensus — we are less willing to pay up front for a mid-cycle recovery, and we weight the cyclical downside more heavily than a 43-Buy / 0-Sell sell-side book does. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). ADI is a high-quality compounder, not an exponential:
Forward growth: revenue CAGR FY25→FY29E ~14.6% ($11.0B → $18.99B) on consensus; adjusted-EPS CAGR ~14% ($8–9 normalized → ~$17). Solid for a mature semi, but not hypergrowth.
Acceleration (the 2nd derivative) is cyclical, not secular: revenue −23% (FY24) → +17% (FY25) → +33% (FY26E) → +15% (FY27E) → +10% (FY28E) → +2% (FY29E). The steep FY26E jump is the recovery snapback off the FY24 trough; the second derivative then rolls back toward low-single-digit through-cycle growth. This is the signature of a cyclical rebound, not the sustained acceleration our flagship philosophy hunts for. We pick forward next-exponentials, and ADI is a trailing-quality analog compounder.
Room to run: the analog/mixed-signal TAM is large and growing (edge sensing, electrification, AI-server power) but ADI at $184B is already a share leader; a 3× from here implies a ~$550B semiconductor company — plausible over a decade but not fast. The Empower/power-management leg (the KB claim) is the most credible new content driver.
Reinvestment runway: modest capex (~$0.5B/yr, ~5% of sales — ADI is fab-lite/hybrid) and heavy cash return (dividends + buybacks ~$4B/yr). This is a return-capital compounder, not a reinvest-for-hypergrowth story.
Exponential Potential: Low-Moderate (4/10). Own ADI, if at all, for durable ~10–14% through-cycle compounding plus a rising dividend — not for a fast multibagger. That honest framing is why ADI is a Watch/satellite, not a flagship exponential.
Revenue: FY25 $11.02B, +16.9% (FY24 $9.43B, −23.4% off FY23's cyclical peak $12.31B). The FY24 trough → FY25 recovery is the whole cyclical story in one line.
Margins: gross 64.5% TTM (elite for semis), EBITDA margin 48.9%, operating ~32.5%, net 26.0% TTM. Margins expand with volume as the fixed cost base leverages — Q2'26 gross profit was $2.44B on $3.62B revenue (67.3%), above the TTM average, confirming the operating-leverage recovery.
Earnings (GAAP vs adjusted — important): FY25 GAAP net income $2.27B, diluted EPS $4.56. But GAAP is depressed by ~$2B/yr of acquisition amortization (Linear/Maxim). TTM GAAP EPS ~$6.73; the Street's ~$12.32 FY26E is on an adjusted (non-GAAP) basis that adds back that amortization. We flag this explicitly so the P/E figures aren't misread. Q2'26 adjusted EPS beat at $3.09 vs $2.89 est.
Cash flow: FY25 operating CF $4.81B, capex just −$0.53B, FCF $4.28B (39% of revenue — outstanding cash conversion). FCF comfortably funds the ~$1.9B dividend and ~$2.2B buyback.
Balance sheet: total debt $8.66B, net debt $6.17B, net-debt/EBITDA 1.0× — comfortably investment-grade (agency letter rating B- on the FMP composite is a quant score, not a credit rating). Note: goodwill + intangibles are $35B of $48B total assets (73%) — the legacy of the Linear and Maxim deals, which is why tangible returns look far better than book ROE.
6. Valuation — priced in or room?
ADI is not cheap on any lens. Trailing GAAP P/E ~56× (net income per share TTM $6.80), price/sales 14.4×, EV/EBITDA 30.5×, price/FCF 40×. The bull's defense is the forward curve on adjusted earnings: ~31× FY26E ($12.32) → ~25× FY27E ($14.86) → ~22× FY29E ($17.00) — the multiple compresses as the recovery lifts EPS. But two honest caveats: (1) those are adjusted numbers that exclude ~$2B/yr amortization — on GAAP the multiples are meaningfully higher; (2) the PEG on trailing growth flatters (0.67×) but the forward PEG is 2.7× (FMP), i.e. once you normalize for the post-recovery deceleration, ADI is not cheap relative to growth. A through-cycle DCF frame supports roughly today's price only if the recovery holds and margins stay near peak. Street targets (context): consensus $453.57, high $550, low $360 — our $400 base is below consensus because we discount a fully-priced mid-cycle recovery. Not a value buy; a quality-cyclical-at-a-full-price name.
7. Technicals (from the tech block)
Trend:mixed. $377 sits below the 50-DMA ($408.73) but above the 200-DMA ($317.54) — a near-term pullback within a longer up-trend. MACD −4.63 (negative, short-term momentum has rolled over).
Location:−15.3% off the 52-week high ($445.48), +70.9% off the 52-week low ($220.68). The −15% is also the max drawdown from peak — a real correction from the highs, not a name pinned at its top.
Momentum: RSI(14) 39.7 — near the lower end, not oversold (<30) but weak. No overbought warning; if anything the near-term tape is soft.
Relative strength: ADI +56.7% 12-mo vs SPY +20.6% and QQQ +30.3% — strong on a one-year view (the recovery trade), but +17.6% 3-mo vs QQQ +22.0%, i.e. it has lagged the Nasdaq over the last quarter as the stock corrected.
Read: technicals are cautionary, not confirming. A leadership name that has corrected 15% and slipped below its 50-DMA with negative MACD — consistent with a market that is second-guessing the recovery's durability. For a Watch verdict this is fitting: no urgency to chase; a stabilization back above the 50-DMA (~$409) or a washout toward the 200-DMA (~$318) would be cleaner entries.
8. Moat & competitive position
ADI's moat is classic high-quality analog: (1) breadth and lifecycle — tens of thousands of catalog parts with 10+ year lifecycles, each a small share of any bill-of-materials but collectively very sticky; (2) design-in switching costs — once an ADI converter or power part is qualified into an industrial or automotive design, it stays for the product's life; (3) scale in R&D and process IP — reinforced by the Linear Technology (2017) and Maxim Integrated (2021) acquisitions, which consolidated the high-performance analog space; and (4) an emerging power-management leg (Empower Semiconductor) levered to AI/edge power density — the one point the KB claim underwrites (no_priors-asCgCv2XB4s:0b66ecb601). The competitive frame is a rational oligopoly with Texas Instruments (the scale leader) alongside NXP, STMicro, Monolithic Power, and Microchip.
Peer set (from FMP, market cap): Texas Instruments $267B (the direct analog comp), Dell $262B, Marvell $215B, KLA $308B, Cadence $103B, Synopsys $84m→$84B, NXP $69B, Monolithic Power $63B, STMicro $61B, Strategy/MSTR $30B. Within pure-play analog, ADI ($184B) sits behind TXN on scale but ahead on gross margin and end-market diversification — the two most comparable names are TXN and MPWR; the EDA (CDNS/SNPS) and systems (DELL) peers are less apt comparables.
9. Management, capital allocation & guidance
Capital allocation: shareholder-friendly and disciplined. FY25 returned ~$4.1B (dividends $1.92B + buybacks $2.16B) against $4.28B FCF — essentially full FCF return, funded without stressing the 1.0× leverage. Capex is light (~5% of sales; fab-lite hybrid model). Dividend yield ~1.1%, payout ~60% of GAAP earnings (comfortably lower on FCF). This is a mature return-of-capital profile, appropriate for a company past its heaviest reinvestment phase.
Insider activity: the sampled window shows routine director sales — Karen Golz (1,000 sh @ $411.95, 2026-06-12 filing) and Ray Stata (ADI's co-founder, small programmatic lots totaling ~1,100 sh @ ~$393–399, 2026-06-10). These are small, scheduled diversification trades, no alarming cluster of discretionary selling.
Leadership: CEO/Chair Vincent Roche (long-tenured), CFO Richard Puccio. ADI does not have an expert/management voice ingested in the Synthos KB, so panel coverage is absent — but management's own on-the-record guidance is available.
Management's own guidance (self-interested — half-weight): ADI's fiscal-Q2'26 earnings release (SEC 8-K Item 2.02, filed 2026-05-20) is a genuine earnings release with an explicit forward outlook. In management's words, Q2 revenue and EPS came in "above the high end of our outlook," with CFO Puccio citing "record bookings across our B2B markets of Industrial, Automotive, and Communications" driving a guide for "continued strong growth in the third quarter." The stated fiscal-Q3'26 outlook: revenue ~$3.9B ± $100M, reported operating margin ~39.0% ± 150 bps (adjusted ~49.0%), reported EPS $2.60 ± $0.15 / adjusted EPS $3.30 ± $0.15. Read as management's self-interested framing (they talk their book) and half-weighted accordingly — but it is a real, upbeat, on-the-record guide that squares with the Street's ~$3.90B / $3.33 adjusted-EPS Q3 estimate and the sequential recovery in §5. Gap flagged: no analyst-Q&A transcript or expert-panel coverage on file — the verdict remains quant/fundamentals-driven.
10. Catalysts & what to watch
Next earnings: 2026-08-19 (fiscal Q3'26; Street EPS $3.33, revenue ~$3.90B). The key lines: industrial and automotive bookings/book-to-bill (is the recovery broadening?) and gross-margin trajectory (operating leverage confirmation).
Industrial recovery durability: industrial is 45% of revenue and the swing factor — sustained sequential growth = thesis-confirming; a stall = the bear.
Automotive content: BMS/ADAS content gains vs a softening EV/auto unit backdrop.
Power-management / Empower ramp: the one KB-supported growth leg — evidence of AI/data-center power design wins (no_priors-asCgCv2XB4s:0b66ecb601).
China (~26% of revenue): demand and tariff/export-control headlines.
Thesis tripwires (what would change the call): two consecutive quarters of negative sequential revenue or a book-to-bill back below 1.0 (recovery stalling); gross margin rolling back below ~63% (loss of operating leverage); or a China/auto demand shock. Conversely, a durable up-cycle with margins holding + the multiple cooling toward the low-20s forward would move this from Watch to Buy — Tactical.
11. Key risks
Semiconductor cyclicality (structural): ADI's revenue swung from $12.31B (FY23) to $9.43B (FY24) and back — a 23% peak-to-trough drop. At ~56× GAAP / ~31× forward, a fresh downturn de-rates the stock hard. This is the single biggest risk.
Valuation / de-rating: the recovery is largely priced in; the forward PEG (2.7×) says ADI is not cheap on normalized growth.
China & geopolitics: ~26% of revenue in China; exposed to tariffs, export controls, and local-substitution.
Automotive/EV demand: 30% of revenue; a slowdown in auto builds or EV adoption pace pressures a key growth engine.
Acquisition-heavy book: $35B goodwill+intangibles (73% of assets) from Linear/Maxim depresses GAAP returns and carries impairment risk if end-markets disappoint.
Thin conviction: only 1 KB claim — Synthos cannot corroborate the call with a broad expert panel, so it leans entirely on quant/fundamentals.
12. Verdict, position sizing & monitoring
Watch. ADI is a genuinely elite analog franchise — 64% gross margins, $4.3B FCF, a durable design-in moat, an oligopoly structure, and a real power-management growth leg (the one point our lone expert underwrites). But three things hold it back from a Buy: (1) the stock at ~56× GAAP / ~31× forward already prices a clean cyclical recovery; (2) that recovery is a rebound off a trough, not secular acceleration, so Exponential Potential is genuinely low; and (3) Synthos has almost no independent expert coverage on the name (1 claim), so we cannot corroborate a conviction call. The technicals — a 15% correction below the 50-DMA — echo the market's own hesitation.
Sizing: if an investor already owns it, hold; if initiating, satellite-only, ~1–2%, and prefer scaling in on weakness (toward the 200-DMA ~$318 or on a valuation reset) rather than chasing. For most RIA portfolios, Watch — wait for the cycle/valuation to align.
Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $377.16.
Single biggest risk: the semiconductor cycle — a fully-priced recovery meets a mature cyclical, and a demand stall (industrial, auto, or China) would de-rate the stock quickly.
Provenance & disclosures
Traceability: 1 KB claim, breadth 1, top skill 1.0 (no_priors), last claim 2026-06-18 — reconciled to a real claim_id (no_priors-asCgCv2XB4s:0b66ecb601, cited inline). This is thin coverage; the verdict is explicitly fundamentals- and quant-driven. Fabricated conviction is structurally impossible (claim-ID reconciliation).
Data as-of: fundamentals 2026-05-02 (fiscal Q2'26) · estimates & prices 2026-07-02/03 · expert claim 2026-06-18. Forward figures are analyst consensus (FMP), labeled as estimates; note the GAAP-vs-adjusted EPS gap (~$2B/yr acquisition amortization) throughout §5–§6.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").